Effects of percutaneous balloon mitral valvuloplasty on plasma B-type natriuretic peptide in rheumatic mitral stenosis with and without atrial fibrillation

Journal of Heart Valve Disease

Volumn 14, Issue 4, 2005, Pages 453-459

  Shang, Yunpeng P ^a   Lai, Lei ^a   Chen, Junzhu ^a   Zhang, Furong ^a   Wang, Xingxiang ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HEART STROKE VOLUME; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEMODYNAMICS; HUMAN; MALE; MITRAL VALVE STENOSIS; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHEUMATIC HEART DISEASE; VALVULOPLASTY; BALLOON DILATATION; BLOOD; BLOOD PRESSURE; CASE CONTROL STUDY; DIASTOLE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY;

ATRIAL FIBRILLATION; BALLOON DILATATION; BLOOD PRESSURE; CASE-CONTROL STUDIES; DIASTOLE; HUMANS; MIDDLE AGED; MITRAL VALVE STENOSIS; NATRIURETIC PEPTIDE, BRAIN; RHEUMATIC HEART DISEASE; STROKE VOLUME;

EID: 33644639372     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Packer M. Should B-type natriuretic peptide be measured routinely to guide the diagnosis and management of chronic heart failure? Circulation 2003;108:2950-2953
2. Peter A, Richard M, James MC, et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: Analysis from breathing not properly (BNP) multinational study. Circulation 2002;106:416-422
3. Alan M. B-type natriuretic peptide levels: Diagnostic and prognostic in congestive heart failure. What's next? Circulation 2002;105:2328-2331
4. Denus de S, Pharand C, Williamson DR. Brain natriuretic peptide in the management of heart failure: The versatile neurohormone. Chest 2004;125:652-668
5. Sudoh T, Kangawa K, Minamino N, Matsuo H. A new natriuretic peptide in porcine brain. Nature 1988;332:78-81
6. Tharaux PL, Dussaule JC, Hubert-Brierre J, Vahanian A, Acar J, Ardaillou R. Plasma atrial and brain natriuretic peptides in mitral stenosis treated by valvulotomy. Clin Sci (Lond) 1994;87:671-677
7. Nagaya N, Nishikimi T, Okano Y, et al. Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension. J Am Coll Cardiol 1998;31:202-208
8. Tulevski II, Groenink M, van Der Wall EE, et al. Increased brain and atrial natriuretic peptides in patients with chronic right ventricular pressure overload: Correlation between plasma neurohormones and right ventricular dysfunction. Heart 2001;86:27-30
9. Matsuo K, Nishikimi T, Yutani C, et al. Diagnostic value of plasma levels of brain natriuretic peptide in arrhythmogenic right ventricular dysplasia. Circulation 1998;98:2433-2440
10. Yoshimura M, Yasue H, Okumura K, et al. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation 1993;87:464-469
11. Matsumoto A, Hirata Y, Momomura S, et al. Effects of exercise on plasma level of brain natriuretic peptide in congestive heart failure with and without left ventricular dysfunction. Am Heart J 1995;129:139-145
12. Burger W, Kneissl GD, Kober G, Schrader R. Effect of balloon valvuloplasty for mitral stenosis on right ventricular function. Am J Cardiol 1993;71:994-996
13. Burger W, Illert S, Teupe C, Kneissl GD, Kober G, Schrader R. Right ventricular function in patients with mitral valve stenosis. Effect of balloon mitral valvuloplasty. Z Kardiol 1993;82:545-551
14. Burger W, Brinkies C, Illert S, Teupe C, Kneissl GD, Schrader R. Right ventricular function before and after percutaneous balloon mitral valvuloplasty. Int J Cardiol 1997;58:7-15
15. Nagel E, Stuber M, Hess OM. Importance of the right ventricle in valvular heart disease. Eur Heart J 1996;17:829-836
16. Linderer T, Chatterjee K, Parmley WW, Sievers RE, Glantz SA, Tyberg JV. Influence of atrial systole on the Frank-Starling relation and the end-diastolic pressure-diameter relation of the left ventricle. Circulation 1983;67:1045-1053
17. Shapiro W, Klein G. Alterations in cardiac function immediately following electrical conversion of atrial fibrillation to normal sinus rhythm. Circulation 1968;38:1074-1084
18. Orlando JR, Van Herick R, Aronow WAS, Olson HG. Hemodynamics and echocardiograms before and after cardioversion of atrial fibrillation to normal sinus rhythm. Chest 1979;76:521-526
19. Tuinenburg AE, Brundel BJ, Van Gelder IC, et al. Gene expression of the natriuretic peptide system in atrial tissue of patients with paroxysmal and persistent atrial fibrillation. J Cardiovasc Electrophysiol 1999;10:827-835
20. Inoue S, Murakami Y, Sano K, Katoh H, Shimada T. Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation. J Card Fail 2000;6:92-96
21. Naito M, David D, Michelson EL, Schaffenburg M, Dreifus LS. The hemodynamic consequences of cardiac arrhythmias: Evaluation of the relative roles of abnormal atrioventricular sequencing, irregularity of ventricular rhythm and atrial fibrillation in a canine model. Am Heart J 1983;106:284-291
22. Daoud EG, Weiss R, Bahu M, et al. Effect of an irregular rhythm on cardiac output. Am J Cardiol 1996;78:1433-1436
23. Clark DM, Plumb VJ, Epstein AE, Kay GN. Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. J Am Coll Cardiol 1997;30:1039-1045
24. Effat M, Schick EC, Martin DT, Gaasch WH. Effect of rhythm regularization on left ventricular contractility in patients with atrial fibrillation. Am J Cardiol 2000;85:114-116
25. American Society of Echocardiography Committee on Standards, Sub Committee on Quantification of Two-Dimensional Echocardiograms. Recommendations for quantification of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989;2:358-367
26. Jourdain P, Bellorini M, Funck FM, et al. Short-term effects of sinus rhythm restoration in patients with lone atrial fibrillation: A hormonal study. Eur J Heart Fail 2002;4:263-267
27. Ohta Y, Shimada T, Yoshitomi H, et al. Drop in plasma brain natriuretic peptide levels after successful direct current cardioversion in chronic atrial fibrillation. Can J Cardiol 2001;17:415-420
28. Mabuchi N, Tsutamoto T, Maeda K, Kinoshita M. Plasma cardiac natriuretic peptides as biochemical markers of recurrence of atrial fibrillation in patients with mild congestive heart failure. Jpn Circ J 2000;64:765-771
29. Leung DY, Davidson PM, Cranney GB, Walsh WF. Thromboembolic risks of left atrial thrombus detected by transesophageal echocardiogram. Am J Cardiol 1997;79:626-629
30. Zabalgoitia M, Halperin JL, Pearce LA, Blackshear JL, Asinger PW, Hart RG. Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. J Am Coll Cardiol 1998;31:1622-1626
31. Fatkin D, Kelly RP, Feneley MP. Relationship between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo. J Am Coll Cardiol 1994;23:961-969
32. Shimizu H, Murakami Y, Inoue S, et al. High plasma brain natriuretic polypeptide level as a marker of risk for thromboembolism in patients with nonvalvular atrial fibrillation. Stroke 2002;33:1005-1010
33. Igarashi Y, Kashimura K, Makiyama Y, Sato T, Ojima K, Aizawa Y. Left atrial appendage dysfunction in chronic nonvalvular atrial fibrillation is significantly associated with an elevated level of brain natriuretic peptide and a prothrombotic state. Jpn Circ J 2001;65:788-792